<DOC>
	<DOCNO>NCT02580591</DOCNO>
	<brief_summary>The study investigate efficacy , safety , tolerability PK 3 dos empagliflozin compare placebo 26 week 960 patient type 1 diabetes mellitus adjunctive therapy insulin</brief_summary>
	<brief_title>Empagliflozin Adjunctive Insulin Therapy Over 26 Weeks Patients With T1DM ( EASE-3 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Empagliflozin</mesh_term>
	<criteria>Inclusion criterion : Signed date write informed consent Male female patient receive insulin treatment document diagnosis type 1 diabetes mellitus ( T1DM ) &gt; 1 year Cpeptide value &lt; 0.7 ng/mL Use Multiple Daily Injections ( MDI ) insulin insulin pump user total daily insulin &gt; = 0.3 &lt; = 1.5 U/kg Glycated haemoglobin ( HbA1c ) &gt; = 7.5 % &lt; = 10.0 % Good understanding T1DM Age &gt; = 18 year Body Mass Index ( BMI ) &gt; = 18.5 kg/m2 Estimated glomerular filtration rate &gt; = 30 mL/min/1.73 m2 Women childbearing potential must use highly effective method birth control Compliance trial medication administration 80 % 120 % placebo runin period Further inclusion criterion apply Exclusion criterion : History type 2 diabetes mellitus , maturity onset diabetes young ( MODY ) , pancreatic surgery chronic pancreatitis Pancreas , pancreatic islet cell renal transplant recipient T1DM treatment antihyperglycaemic drug except subcutaneous basal bolus insulin within last 3 month Occurrence severe hypoglycaemia within last 3 month randomisation Occurence diabetic ketoacidosis within 3 month prior Visit 1 Visit 6 Irregular sleep/wake cycle Acute coronary syndrome , stroke TIA within last 3 month Severe gastroparesis Brittle diabetes Liver disease Eating disorder Treatment antiobesity drug , weightloss surgery aggressive diet regimen Treatment systemic corticosteroid Change dose thyroid hormone within last 6 week randomisation Cancer treatment cancer last five year Blood dyscrasia disorder cause haemolysis unstable red blood cell Women pregnant , nursing , plan become pregnant whilst trial Alcohol drug abuse Intake investigational drug another trial within last 30 day Further exclusion criterion apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>